Companies

CG Oncology, Inc. (CGON) SEC filings

CIK 0001991792 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025
Net income (USD)-48.6 M
Diluted EPS (USD/shares)-2.08

Latest filings

FiledFormDescriptionPeriod
2026-10-19442026-10-15
2026-10-19442026-10-15
2026-10-19332026-10-13
2026-10-15144144
2026-09-21144144
2026-09-17144144
2026-09-17442026-09-15
2026-09-11144144
2026-09-02144144
2026-08-31144144
2026-08-27144144
2026-08-25144144
2026-08-24144144
2026-08-19144144
2026-08-18442026-08-14
2026-08-17144144
2026-08-14144144
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-13144144
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-12144144
2026-08-11144144
2026-08-10144144
2026-08-07144144

Forms on file (last 1,000): 4 76, 144 45, 8-K 29, 3 16, SCHEDULE 13G/A 9, 10-Q 8, SC 13G 8, CORRESP 6. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=CGON (0.002 USD), /gw/filings/filings?ticker=CGON&form=8-K, /gw/filings/facts?ticker=CGON&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange